Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease
- PMID: 11029323
- DOI: 10.1164/ajrccm.162.4.9909120
Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease
Abstract
Angiotensin converting enzyme (ACE) plays an important role in the pathogenesis of pulmonary hypertension. In this study we determined whether the deletion (D)/insertion (I) polymorphism in the ACE gene may be associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease (COPD). ACE genotypes were determined in 19 patients with COPD. All patients underwent right heart catheterization followed by a constant-load exercise test while breathing room air or oxygen. Subgroups were created of seven patients with the II genotype, six with the ID genotype, and six with the DD genotype who were well-matched with respect to age, blood gas data at rest or after exercise, baseline lung function, results of incremental exercise testing, and hemodynamic data at rest. The mean pulmonary arterial pressure (Ppa) and pulmonary vascular resistance (Rpv) at rest in the three subgrpoups did not differ significantly during breathing of either room air or oxygen. However, the Ppa after exercise challenge in patients with the DD genotype (55.7 +/- 4.9 mm Hg [mean +/- SD]) was significantly higher than in patients with the II genotype (42.6 +/- 7.1 mm Hg, p = 0.008). The Rpv after exercise in patients with the DD genotype was also significantly higher than in patients with the ID and II genotypes. During breathing of oxygen to diminish acute hypoxic pulmonary vasoconstriction, the Ppa in patients with the DD genotype (52.3 +/- 3.1 mm Hg) was higher than in patients with the ID genotype (40.5 +/- 5.9 mm Hg, p = 0.0049) or the II genotype (37.7 +/- 5.9 mm Hg, p = 0.0027). In addition, the Rpv in patients with the DD genotype was higher than in patients with the ID and II genotypes. These results suggest that D-I polymorphism in the ACE gene may be associated with pulmonary hypertension evoked by exercise challenge in patients with COPD. However, the number of patients in this study was very small for a genetic association study, and our results should be examined in larger studies.
Similar articles
-
Acute effects of nifedipine administration in pulmonary haemodynamics and oxygen delivery during exercise in patients with chronic obstructive pulmonary disease: implication of the angiotensin-converting enzyme gene polymorphisms.Clin Physiol Funct Imaging. 2004 Jul;24(4):224-8. doi: 10.1111/j.1475-097X.2004.00552.x. Clin Physiol Funct Imaging. 2004. PMID: 15233837 Clinical Trial.
-
The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD.Wien Klin Wochenschr. 2005 Mar;117(5-6):210-4. doi: 10.1007/s00508-005-0333-z. Wien Klin Wochenschr. 2005. PMID: 15875760
-
Influence of oxygen administration on pulmonary haemodynamics and tissue oxygenation during exercise in COPD patients with different ACE genotypes.Clin Physiol Funct Imaging. 2003 Nov;23(6):332-6. doi: 10.1046/j.1475-0961.2003.00515.x. Clin Physiol Funct Imaging. 2003. PMID: 14617263 Clinical Trial.
-
Increased Frequency of Angiotensin-Converting Enzyme D Allele in Asian Patients With Chronic Obstructive Pulmonary Disease: An Updated Meta-Analysis.Clin Respir J. 2024 Aug;18(8):e70002. doi: 10.1111/crj.70002. Clin Respir J. 2024. PMID: 39188047 Free PMC article. Review.
-
Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.Thorax. 1999 Mar;54(3):245-52. doi: 10.1136/thx.54.3.245. Thorax. 1999. PMID: 10325902 Free PMC article. Review. No abstract available.
Cited by
-
ACE2, a promising therapeutic target for pulmonary hypertension.Curr Opin Pharmacol. 2011 Apr;11(2):150-5. doi: 10.1016/j.coph.2010.12.002. Epub 2011 Jan 5. Curr Opin Pharmacol. 2011. PMID: 21215698 Free PMC article. Review.
-
ACE gene polymorphism is associated with COPD and COPD with pulmonary hypertension: a meta-analysis.Int J Chron Obstruct Pulmon Dis. 2018 Aug 13;13:2435-2446. doi: 10.2147/COPD.S168772. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30147309 Free PMC article.
-
The Biological Bases of Group 2 Pulmonary Hypertension.Int J Mol Sci. 2019 Nov 23;20(23):5884. doi: 10.3390/ijms20235884. Int J Mol Sci. 2019. PMID: 31771195 Free PMC article. Review.
-
Associations between endothelial nitric oxide synthase A/B, angiotensin converting enzyme I/D and serotonin transporter L/S gene polymorphisms with pulmonary hypertension in COPD patients.Mol Biol Rep. 2013 Oct;40(10):5625-33. doi: 10.1007/s11033-013-2664-6. Epub 2013 Sep 21. Mol Biol Rep. 2013. PMID: 24057178
-
Hypoxemia in patients with COPD: cause, effects, and disease progression.Int J Chron Obstruct Pulmon Dis. 2011;6:199-208. doi: 10.2147/COPD.S10611. Epub 2011 Mar 14. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 21660297 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous